ABSTRACT
29
shows that each mutation confers small local changes. The loss of a hydrogen bond and 30 introduction of a glycine residue likely introduce flexibility to sites that control interactions with 31 the host receptor, antibodies, and sialic acids. 
44
Additionally, these four mutations have been shown to alter antibody binding, as they cluster to 45 a position on the capsid surface where an antigenic site overlaps with the receptor-binding site
46
(5-8). Besides these four mutations, there are other changes seen between CPV-2 and later
47
isolates that became globally distributed. VP2 residue 375, which was an Asp in both FPV and 48 CPV-2a, is an Asn in most CPV-2 isolates. VP2 residue 426, changed from Asn to Asp and 49 then from Asp to Glu in the so-called CPV-2b and -2c antigenic variant strains, respectively (9, 50 10). However, as the CPV-2b and -2c antigenic strains differ from CPV-2a at only one position (VP2 residue 426), they are now considered to be variants of CPV-2a rather than distinct 52 subtypes, as are all of the CPVs circulating worldwide today.
53
One of the major biological differences between CPV-2 and CPV-2a was the ability of 54 the latter to infect cats in vivo. This extended feline host tropism of CPV-2a was shown to be 55 due to changes within VP2, demonstrating that subtle alterations in the capsid region could 56 influence the tropism and host range of the virus (11, 12) . Overall, the amino acid changes 57 observed between the capsids of CPV-2 and CPV-2a altered their phenotypes by specifically 58 conferring changes in the binding of the virus to the carnivore TfR, the antigenicity of the virus,
59
and the pH-dependent binding of sialic acid (3, (7) (8) (9) (10) (11) (Table 1) .
86
For the structure solution and refinement of the CPV-2a variant, diffraction images were 
96
The structures of CPV-2a and CPV-2 superimposed with a RMSD = 0.55Å indicating 97 high structural similarity. In addition to the four mutations in the capsid protein previously 98 characterized, M87L, I101T, A300G, D305Y, we also examined N375D and N426D, which 
110
In addition, Gly 300 is within one of the major antigenic sites (site "B") on the capsid (7, 
138
In conclusion, the profound impact of the CPV-2a-associated mutations on the success 
